Archive for Author 'Ronstadt Insurance'
+10.2% Increase Driven by Weight Loss Meds
Prescription drug spending in the U.S. jumped 10.2% in 2024, reaching $806 billion, according to the ASHP. The surge is fueled by skyrocketing demand for GLP-1 drugs (like Ozempic & Wegovy), now the #1 drug category and fastest-growing segment.
“GLP-1s are changing metabolic care—but they expose supply chain risks.”
— Eric Tichy, PharmD, ASHP
Right now, Congress is considering the Healthcare Affordability Act (H.R. 247 / S. 46)—a crucial piece of legislation that would permanently extend the enhanced ACA premium tax credits. These credits, which have helped millions of Americans afford health coverage since 2021, are set to expire at the end of 2025.
Without this bill, the consequences will be immediate and devastating—for your clients, your business, and the stability of the entire individual health insurance market.
If these enhanced credits disappear:
